Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $320

Benzinga · 2d ago
Morgan Stanley analyst Patrick Moley maintains CME Group (NASDAQ:CME) with a Overweight and raises the price target from $314 to $320.